Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Persoonlijk profiel
Expertise gerelateerd aan duurzame ontwikkelingsdoelstellingen van de VN
In 2015 stemden de VN-lidstaten in met 17 wereldwijde duurzame ontwikkelingsdoelstellingen (Sustainable Development Goals, SDG's) om armoede te beëindigen, de planeet te beschermen en voor iedereen welvaart te garanderen. Het werk van deze persoon draagt bij aan de volgende duurzame ontwikkelingsdoelstelling(en):
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Annemiek Walenkamp-Hageman actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
Cancer survivors' experiences of a physical activity program in primary care: a qualitative study
Huizinga, F., Kieboom, E. A. M., de Greef, M. H. G., Walenkamp, A. M. E., Berendsen, A. J., Berger, M. Y. & Brandenbarg, D., 22-mrt.-2024, (E-pub ahead of print) In: Journal of cancer survivorship-Research and practice. 10 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand40 Downloads (Pure) -
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial
EORTC Brain Tumor Group, Canadian Cancer Trials Group, Roth, P., Gorlia, T., Reijneveld, J. C., de Vos, F., Idbaih, A., Frenel, J. S., Rhun, E. L., Sepulveda, J. M., Perry, J., Masucci, G. L., Freres, P., Hirte, H., Seidel, C., Walenkamp, A., Lukacova, S., Meijnders, P., Blais, A. & Ducray, F. & 12 anderen, , 1-sep.-2024, In: Neuro-Oncology. 26, 9, blz. 1670-1682 13 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand6 Citaten (Scopus)16 Downloads (Pure) -
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen
Malta, T. M., Sabedot, T. S., Morosini, N. S., Datta, I., Garofano, L., Vallentgoed, W., Varn, F. S., Aldape, K., D'Angelo, F., Bakas, S., Barnholtz-Sloan, J. S., Gan, H. K., Hasanain, M., Hau, A. C., Johnson, K. C., Cazacu, S., deCarvalho, A. C., Khasraw, M., Kocakavuk, E. & Kouwenhoven, M. C. M. & 23 anderen, , 1-mrt.-2024, In: Cancer Research. 84, 5, blz. 741-756 16 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand19 Citaten (Scopus)27 Downloads (Pure) -
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma
Janssen, J. B. E., Brahm, C. G., Driessen, C. M. L., Nuver, J., Labots, M., Kouwenhoven, M. C. M., Aliaga, E. S., Enting, R. H., de Groot, J. C., Walenkamp, A. M. E., van Linde, M. E. & Verheul, H. M. W., 2024, In: Brain Communications. 6, 4, 12 blz., fcae241.Onderzoeksoutput › Academic › peer review
Open AccessBestand20 Downloads (Pure) -
Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy - pulmonary and vascular endothelial function: an exploratory analysis
van der Schoot, G. G. F., Ormel, H. L., Westerink, N.-D. L., Wempe, J. B., Lefrandt, J. D., May, A. M., Vrieling, A. H., Meijer, C., Gietema, J. A. & Walenkamp, A. M. E., dec.-2023, In: Journal of cancer research and clinical oncology. 149, blz. 17467–17478 12 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand2 Citaten (Scopus)42 Downloads (Pure)
Activiteiten
-
The value of circulating tumor DNA in neuroendocrine neoplasms
Walenkamp-Hageman, A. (Invited speaker)
14-sep.-2024Activiteit: Academic presentation › Academic
-
Infrastructure for cancer care in Europe
Walenkamp-Hageman, A. (Invited speaker)
3-okt.-2024Activiteit: Academic presentation › Academic
-
Examination of PhD H.L. Ormel
Walenkamp-Hageman, A. (Supervisor) & Gietema, J. (Supervisor)
26-feb.-2024Activiteit: Supervision and examination of PhD students of the UG › Academic
-
ESMO Congress 2024
Walenkamp-Hageman, A. (Member of scientific committee)
2024 → …Activiteit: Organising and contributing to an event › Academic
-
Dutch Cancer Society (KWF Kankerbestrijding) (Externe Organisatie)
Walenkamp-Hageman, A. (Advisor), May, A. (Advisor) & Kok, D. (Advisor)
2024 → …Activiteit: Membership › Professional
Datasets
-
Additional file 10 of Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
Heidegger, I. (Contributor), Fotakis, G. (Contributor), Offermann, A. (Contributor), Keller, M. A. (Contributor), Wolf, D. (Contributor), Schäfer, G. (Contributor), Haybaeck, J. (Contributor), Daum, S. (Contributor), Krogsdam, A. (Contributor), Klocker, H. (Contributor), Pircher, A. (Contributor), Noureen, A. (Contributor), Plattner, C. (Contributor), Timmer-Bosscha, H. (Contributor), Goveia, J. (Contributor), Salcher, S. (Contributor), Walenkamp, A. (Contributor), Beatovic, A. (Contributor), Sopper, S. (Contributor), Trajanoski, Z. (Contributor), Moisse, M. (Contributor), Thaler, S. (Contributor) & Perner, S. (Contributor), figshare Academic Research System, 19-jun.-2022
DOI: 10.6084/m9.figshare.20098784.v1
Dataset
-
Additional file 6 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
van Rooijen, J. (Contributor), Timmer-Bosscha, H. (Contributor), Van Deurzen, C. H. M. (Contributor), Van Leeuwen-Stok, E. (Contributor), van der Vegt, B. (Contributor), de Bock, T. (Contributor), Nienhuis, H. (Contributor), Qiu, S. (Contributor), Schröder, C. (Contributor), de Vries, L. (Contributor) & Walenkamp-Hageman, A. (Contributor), University of Groningen, 19-mrt.-2020
DOI: 10.6084/m9.figshare.12004500.v1
Dataset
-
Additional file 4 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
van Rooijen, J. (Contributor), Nienhuis, H. (Contributor), Van Leeuwen-Stok, E. (Contributor), de Bock, T. (Contributor), van der Vegt, B. (Contributor), Qiu, S. (Contributor), Van Deurzen, C. H. M. (Contributor), Timmer-Bosscha, H. (Contributor), de Vries, L. (Contributor), Walenkamp-Hageman, A. (Contributor) & Schröder, C. (Contributor), University of Groningen, 19-mrt.-2020
DOI: 10.6084/m9.figshare.12004491.v1
Dataset
-
Additional file 5 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
Van Deurzen, C. H. M. (Contributor), Walenkamp-Hageman, A. (Contributor), Nienhuis, H. (Contributor), de Bock, T. (Contributor), van der Vegt, B. (Contributor), van Rooijen, J. (Contributor), Van Leeuwen-Stok, E. (Contributor), Schröder, C. (Contributor), Qiu, S. (Contributor), de Vries, L. (Contributor) & Timmer-Bosscha, H. (Contributor), University of Groningen, 31-mrt.-2020
DOI: 10.6084/m9.figshare.12004494.v1, https://doi.org/10.6084%2Fm9.figshare.12004494.v1
Dataset
-
Additional file 8 of Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
Heidegger, I. (Contributor), Fotakis, G. (Contributor), Offermann, A. (Contributor), Schäfer, G. (Contributor), Klocker, H. (Contributor), Daum, S. (Contributor), Salcher, S. (Contributor), Noureen, A. (Contributor), Goveia, J. (Contributor), Krogsdam, A. (Contributor), Beatovic, A. (Contributor), Timmer-Bosscha, H. (Contributor), Trajanoski, Z. (Contributor), Thaler, S. (Contributor), Pircher, A. (Contributor), Moisse, M. (Contributor), Perner, S. (Contributor), Plattner, C. (Contributor), Wolf, D. (Contributor), Walenkamp, A. (Contributor), Sopper, S. (Contributor), Haybaeck, J. (Contributor) & Keller, M. A. (Contributor), figshare Academic Research System, 19-jun.-2022
DOI: 10.6084/m9.figshare.20098808.v1
Dataset
Knipsels
-
De ontwikkeling van FORCE, een landelijke infrastructuur om informatie over zeldzame tumoren te bundelen en toegankelijk te maken
01/07/2023
1 Mediabijdrage
Pers / media: Activiteiten met een maatschappelijk belang › Professional
-
‘Zonder stok achter de deur was ik eerder gestopt’
15/12/2022
1 Mediabijdrage
Pers / media: Expert Comment › Popular
-
‘Twee weken na de chemo kon ik weer fulltime aan het werk’
25/11/2022
1 item van Media-aandacht
Pers / media: Expert Comment › Popular
-
Exercise During Chemo Shows Benefits for Cardiorespiratory Fitness
21/11/2022
1 item van Media-aandacht
Pers / media: Expert Comment › Popular
-
Exercise During Chemo May Help You Beat the Treatment’s Effects
02/11/2022
2 items van Media-aandacht
Pers / media: Expert Comment › Popular
Prijzen
-
UMCG Awarded ENETS Center of Excellence for Tumorgroup NET/NEC
Walenkamp-Hageman, A. (Recipient), 2022
Prijs: Other distinction › Professional
-
Infrastructural grant FORCE; Infrastructure for rare cancer in the Netherlands (€3.200.000,--)
Walenkamp-Hageman, A. (Recipient), 2021
Prijs: Other distinction › Academic
-
Educational grant IPSEN: “Multi-disciplinary website to inform patients with neuroendocrine tumors”. PI. (€50.000,--)
Walenkamp-Hageman, A. (Recipient), 2020
Prijs: Other distinction › Academic
-
Grant: UMCG Cancer Researchfund: “Non-invasive evaluation of oxidative muscle metabolism in patients with testicular cancer enrolled in the UMCG ACT trial” (€3.000,--)
Walenkamp-Hageman, A. (Recipient), 2020
Prijs: Other distinction › Academic
-
Educational grant IPSEN: “Multi-disciplinary approach in neuroendocrine tumor patients”. PI. (€200.000,--)
Walenkamp-Hageman, A. (Recipient), 2017
Prijs: Other distinction › Academic